Literature DB >> 3474152

Activated H-ras transforms rat intestinal epithelial cells with expression of alpha-TGF.

R N Buick, J Filmus, A Quaroni.   

Abstract

We describe malignant transformation of cultured rat intestinal epithelial cells (IEC-18) by transfection with the activated human H-ras gene cloned from the EJ bladder carcinoma. Transformed cells showed a marked morphological change, expressed high levels of the transfected H-ras gene, were able to grow in agar and expressed antigenic markers identical with parental IEC-18 cells. When injected into syngeneic rats these cells formed rapidly growing tumors expressing the same intestinal-specific antigenic markers as the injected cells. Parallel to the high expression of H-ras mRNA in the transformants we document overexpression of rat alpha-TGF mRNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474152     DOI: 10.1016/0014-4827(87)90308-9

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cell variants selected for resistance to anoikis.

Authors:  J Rak; Y Mitsuhashi; C Sheehan; J K Krestow; V A Florenes; J Filmus; R S Kerbel
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Normal rat intestinal cells IEC-18: characterization and transfection with immortalizing oncogenes.

Authors:  O Vincentini; C Ciotta; M Bignami; A Stammati; F Zucco
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine.

Authors:  J Filmus; J G Church; R N Buick
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

4.  Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells.

Authors:  F Okada; J W Rak; B S Croix; B Lieubeau; M Kaya; L Roncari; S Shirasawa; T Sasazuki; R S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 5.  Oncogenes as inducers of tumor angiogenesis.

Authors:  J Rak; J Filmus; G Finkenzeller; S Grugel; D Marmé; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

6.  Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.

Authors:  Dharini van der Hoeven; Kwang-jin Cho; Xiaoping Ma; Sravanthi Chigurupati; Robert G Parton; John F Hancock
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

7.  Syndecan-1 is up-regulated in ras-transformed intestinal epithelial cells.

Authors:  Z M Wong; B Choo; M Li; D J Carey; D F Cano-Gauci; R N Buick
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

8.  Oncogenic RAS drives the CRAF-dependent extracellular vesicle uptake mechanism coupled with metastasis.

Authors:  Dongsic Choi; Laura Montermini; Brian Meehan; Anthoula Lazaris; Peter Metrakos; Janusz Rak
Journal:  J Extracell Vesicles       Date:  2021-06-10

9.  Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis.

Authors:  Hao-Hsuan Jeng; Laura J Taylor; Dafna Bar-Sagi
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression.

Authors:  J Rak; Y Mitsuhashi; V Erdos; S N Huang; J Filmus; R S Kerbel
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.